SuperX
  1. Home
  2. Stocks
  3. SAPL

No trade has been recorded for SAPL since 27 Oct 2023 — 1,120 days before 20 Nov 2026. The figures on this page are from that session.

SAPL Sanofi-Aventis Pakistan share price

Sanofi-Aventis Pakistan in one paragraph

Sanofi-Aventis Pakistan (SAPL) last traded at Rs 870.00 on 27 Oct 2023. Its market capitalisation is about Rs 8.4B. Sanofi-Aventis Pakistan is in the Pharmaceuticals sector.

Close · 27 Oct 2023 · Pakistan Stock Exchange · Vol 650

Rs 870.00

0.00 (0.00%)

Chart SAPL in SuperX Apex
SAPL · 1-year close

No price history available for this symbol yet.

1 week
+24.29%
1 month
+24.64%
3 months
+15.94%
6 months
+24.29%
Year to date
−9.19%
1 year
−22.66%
3 years
+10.13%
5 years
+0.07%
Last price
Rs 870.00
27 Oct 2023
Change on the day
0.00%
Rs 0.00
Market cap

Market cap

What the whole company costs at today's price.

How it's worked out

Share price multiplied by every share in issue.

How to read it

It is the company's size, not its value. A big number does not mean the price is high against earnings, and a small one does not mean it is low — that is what the ratios below are for.

Rs 8.4B
as of 20 Nov 2026
Price per rupee earned

Price per rupee earned

Rupees you pay for each rupee the company earned last year.

How it's worked out

Share price divided by earnings per share over the last twelve reported months.

How to read it

Lower only means something against something — the same company's history, its sector, or the market. On its own this ratio says very little, and it is blank when a company lost money.

—
Dividend yield

Dividend yield

Cash paid out over the last year as a percentage of today's price.

How it's worked out

Dividends per share over twelve months divided by the share price.

How to read it

A very high yield is often a warning, not a gift: it usually means the price fell. Check the payout ratio next to see whether earnings actually cover it.

—
Earnings per share
Rs 17.29
the year to 31 Dec 2022
52-week range
—
Day range
—
prev close 870.00
Volume
650
shares, this session
Avg volume (30d)

Average volume

Shares changing hands on a typical day.

How it's worked out

The mean daily volume over thirty sessions.

How to read it

Shares, not rupees — a million shares of a Rs 3 stock is a small market. "Traded per session" is the version in money.

612
6 more figures
Book value / share

Book value per share

The accounting value of one share, in rupees.

How it's worked out

Total equity divided by shares outstanding — what each share would be worth if the company sold everything at balance-sheet value and paid off every debt.

How to read it

The floor under a share price, loosely. It ignores brands, people and future profits, so a good business trades well above it and a broken one below.

Rs 523.72
accounts to 31 Dec 2022
Shares outstanding

Shares outstanding

Every share the company has issued.

How it's worked out

The share count in the company's own filings, including the blocks nobody trades.

How to read it

Divide any per-share figure by this. It is larger than the free float on almost every PSX name, because sponsors and the government own shares that never reach the market.

9.6M
Free float

Free float

The shares that can actually be bought and sold.

How it's worked out

Total shares minus the blocks held by sponsors, the government and other locked-in holders, as the exchange reports them.

How to read it

The float, not the market cap, is what sets how easily a real position can be built or unwound.

964K
10% of shares
Last results filed
23 Oct 2023
Shariah
—

Figures as of 27 Oct 2023.

There is no SuperX note for Sanofi-Aventis Pakistan yet. A note is written after a market close.

01Returns1 year −22.66%
02ValueAgainst the sector

The same ratio on other definitions

SAPL earnings per share: Rs 17.29 · unconsolidated · the year to 31 Dec 2022 · PSX company page

Price per rupee earned, our own: 50.32 (870.00 on 27 Oct 2023 over 17.29, unconsolidated, the year to 31 Dec 2022)

Brokers’ price targets

Brokers’ 12-month price targets for SAPL, not SuperX’s

Collected from sell-side research notes. The figures here are the brokers’.

No broker covers SAPL in our records. Brokers cover 49 PSX companies and rate 47 of them buy.

03Grades and checksGrades A to F
04ResultsBy year and by quarter
Sales, profit and earnings per share, by year

What are SAPL’s sales, profit and earnings per share?

Annual figures from the accounts filed with PSX. Amounts in rupees; earnings per share (EPS) in rupees a share.

Statements in SuperX Apex

FY (December) 2022202120202019
Sales Rs 18.6BRs 15.9BRs 14.1BRs 14.5B
Profit after Taxation Rs 167MRs 906MRs 493MRs 155M
EPS Rs 17.29Rs 93.93Rs 51.12Rs 16.05
EPS Growth −81.6%+83.7%+218.5%−74.7%
Gross Profit Margin 26.2%26.0%27.0%25.7%
Net Profit Margin 0.9%5.7%3.5%1.1%
05AccountsCash, debt and the balance sheet
Balance sheet and returns

Sanofi-Aventis Pakistan balance sheet and returns

Return on equity, book value, gearing and margins for Sanofi-Aventis Pakistan, from the company’s own audited annual report. Figures for the year ended 31 Dec 2022, 10 months old.

Return on equity

Return on equity

What the company earned on the shareholders' own money.

How it's worked out

Profit after tax divided by total equity, both from the balance sheet in the company's latest annual report. PSX publishes no balance sheet, so this is read out of the filing itself.

How to read it

The headline test of whether management is any good. Above about 20% is high for PSX; below the rate a bank deposit pays means the business earns less than doing nothing. Blank on negative equity, where the number flatters instead of informing.

3.31%
Return on assets

Return on assets

Earnings against everything the company controls, not just what shareholders put in.

How it's worked out

Profit after tax divided by total assets, from the annual report's balance sheet.

How to read it

Read it beside return on equity. A wide gap between the two is borrowed money doing the work — on a bank or a leasing company, that gap is the whole story.

1.35%
Book value / share

Book value per share

The accounting value of one share, in rupees.

How it's worked out

Total equity divided by shares outstanding — what each share would be worth if the company sold everything at balance-sheet value and paid off every debt.

How to read it

The floor under a share price, loosely. It ignores brands, people and future profits, so a good business trades well above it and a broken one below.

Rs 523.72
Price to book

Price to book

What the market charges for each rupee of net assets.

How it's worked out

Share price divided by book value per share.

How to read it

Under 1 means the market values the whole company at less than the net assets on its own balance sheet. On PSX that is common and is sometimes a bargain and sometimes a warning — check why.

1.66×
Current ratio

Current ratio

Can it pay the bills due inside a year?

How it's worked out

Current assets divided by current liabilities, from the annual report.

How to read it

Under 1 means more falls due within a year than the company expects to collect within one. Not fatal on its own — but it is the first place to look when a company is in trouble.

1.41×
Liabilities to equity

Liabilities to equity

How much is owed against how much is owned outright.

How it's worked out

Total liabilities divided by total equity. The broad measure — all liabilities, not only interest-bearing borrowings — because that is what the published tables reliably carry.

How to read it

Leverage magnifies both directions. High gearing is normal for banks and leasing, alarming for a manufacturer in a high-rate year like Pakistan has had.

1.44×
Funded by shareholders

Funded by shareholders

The share of the balance sheet shareholders actually paid for.

How it's worked out

Total equity as a percentage of total assets — the plain-English complement of leverage.

How to read it

The higher it is, the less the company depends on lenders staying friendly. At Pakistani interest rates that dependence has cost a great deal.

41%
Gross margin

Gross margin

What's left of each sales rupee after the cost of making the thing.

How it's worked out

Gross profit as a percentage of sales, from the annual report.

How to read it

Pricing power in one number. A margin that holds while the rupee falls means the company can pass costs on; one that shrinks means it cannot.

26.24%
Operating margin

Operating margin

What's left of each sales rupee after running the business.

How it's worked out

Operating profit as a percentage of sales — after overheads, before interest and tax.

How to read it

The cleanest view of the business itself, stripped of how it is financed and taxed.

4.17%
Effective tax rate

Effective tax rate

The share of pre-tax profit that actually went to the FBR.

How it's worked out

Taxation divided by profit before tax, from the annual report. Blank on a pre-tax loss, where the ratio inverts and means nothing.

How to read it

Pakistan's headline corporate rate plus super tax means many companies pay far more than 29%. A rate well above peers is a real drag on what reaches shareholders.

77%
Year ended Total assets Equity Revenue Profit Return on equity
31 Dec 2022accounts not labelled Rs 12.3B Rs 5.1B Rs 18.6B Rs 167M 3.3%
31 Dec 2021accounts not labelled Rs 9.3B Rs 5.2B Rs 15.9B Rs 906M 17.4%
31 Dec 2020accounts not labelled Rs 8.7B Rs 4.7B Rs 14.1B Rs 493M 10.5%
31 Dec 2019accounts not labelled Rs 7.7B Rs 3.9B Rs 14.5B Rs 155M 4.0%
31 Dec 2018accounts not labelled Rs 7.8B — Rs 13B Rs 613M —
31 Dec 2017accounts not labelled Rs 6.6B Rs 4.1B Rs 12.4B Rs 1B 24.3%

Source: Sanofi-Aventis Pakistan’s annual report, page 112. Every figure above can be checked against it.

06DividendsEvery payout
Every payout

SAPL dividends and corporate actions

PSX quotes payouts as a % of the Rs 10 face value — 25% = Rs 2.50 per share. Unconfirmed ex-dates are marked “expected”.

Payouts in SuperX Apex

SAPL dividends and corporate actions
Type % of face Per share Ex-date Book closure Qualify by
No dividends or corporate actions on record for SAPL.
07Peers6 companies
Peers table

Other Pharmaceuticals stocks on PSX

Other companies in the same PSX sector, including its largest.

SAPL sector peers
Symbol Company Price Chg % Mkt cap Price/earnings
SEARL The Searle Company Limited 79.69 +0.18% Rs 46.9B 12.1×
WYETH Wyeth Pakistan Limited 2,007.70 0.00% —
ABOT Abbott Laboratories (Pakistan) Limited 1,013.28 +0.42% Rs 99.2B 10.7×
GLAXO GlaxoSmithKline Pakistan Limited 332.02 −0.92% Rs 106B 9.6×
HALEON Haleon Pakistan Limited 687.73 0.00% Rs 80.5B 12.3×
HINOON Highnoon Laboratories Limited 976.84 +1.74% Rs 51.8B 12.6×

5 of 6 companies shown have a price-to-earnings ratio in Pharmaceuticals; a blank cell means a loss or no ratio. Each ratio is the one printed on that company’s own page.

All Pharmaceuticals stocks on PSX

08Price position52-week range and readings
09OwnersWho owns the shares
About the company

About Sanofi-Aventis Pakistan Limited

The Company was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 (now Companies Act, 2017). The Company is a subsidiary of Sanofi Foreign Participations B.V. registered in Netherlands. The ultimate parent of the Company is Sanofi S.A., France. The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products.

Head office
Plot No 23, Sector 22 Korangi Industrial Area Karachi, Pakistan.
Auditor
A. F. Ferguson & Co. Chartered Accountants
Share registrar
FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi
Fiscal year end
December
10Dated record22 dated events
The dated record

SAPL’s dated record

The exchange’s own record and ours: ex-dividends, book closures, results, every session move of 3% or more with the reason written out, the notices that move a price, and the news about Sanofi-Aventis Pakistan. Dates that have not happened are kept apart from dates that have, and each one says whether it was announced or projected.

Earlier · 22

Notice 20 notices, 26 Aug 2021 to 23 Oct 2023 open
  • 23 Oct 2023 Financial results Financial Results for the Period Ended September 30, 2023
  • 13 Oct 2023 Board meeting BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD
  • 25 Aug 2023 Financial results Financial Results for the Half Year Ended June 30, 2023
  • 17 Aug 2023 Board meeting BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD
  • 30 May 2023 Financial results Financial Results for the Period Ended March 31, 2023
  • 23 May 2023 Board meeting BOARD MEETING FOR THE PERIOD ENDED MARCH 31, 2023
  • 20 Apr 2023 Financial results Financial Results for the Year Ended December 31, 2022
  • 19 Apr 2023 Board meeting Board Meeting In Progress
  • 12 Apr 2023 Board meeting Board Meeting for the year ended December 31, 2022
  • 27 Oct 2022 Financial results Financial Results for the Period Ended September 30, 2022
  • 19 Oct 2022 Board meeting Board Meeting for the period ended September 30, 2022
  • 25 Aug 2022 Financial results Financial results for the half year ended June 30, 2022
  • 17 Aug 2022 Board meeting Board Meeting for the half year ended June 30, 2022
  • 28 Apr 2022 Financial results Financial Results for the Quarter Ended March 31, 2022
  • 19 Apr 2022 Board meeting Board Meeting for the Quarter ended March 31, 2022
  • 25 Mar 2022 Financial results Financial Results for the Year Ended December 31, 2021
  • 17 Mar 2022 Board meeting Board Meeting for the Year ended December 31, 2021
  • 27 Oct 2021 Financial results Financial Results for the Period Ended September 30, 2021
  • 14 Oct 2021 Board meeting Board Meeting for the Period Ended September 30, 2021
  • 26 Aug 2021 Financial results Financial Results for the Six Months Ended June 30, 2021
Results 2 results filings, 23 Oct 2023 to 21 Aug 2026 open
  • 21 Aug 2026 Half-year results expected between 21 Aug 2026 and 31 Aug 2026 projected A window from past filings, not a date the company gave.
  • 23 Oct 2023 Nine-month results, to 30 Sep 2023

Showing the most recent notices. Every ex-dividend, book closure, results filing and ticker change is listed.

Dates and events on this page are read as of 20 Nov 2026.

11QuestionsQuick answers

SAPL share price: quick answers

What is the Sanofi-Aventis Pakistan (SAPL) share price?

Sanofi-Aventis Pakistan (SAPL) last traded at Rs 870.00 on 27 Oct 2023.

What is SAPL's dividend yield?

No trailing dividend yield is shown for Sanofi-Aventis Pakistan Limited (SAPL) as of 27 Oct 2023. Check the dividend history table on this page for declared payouts.

How much does SAPL cost for each rupee it earns?

SuperX cannot price SAPL against its earnings as of 27 Oct 2023, because the trailing twelve months show no profit to divide by — the earnings are negative or not yet reported. See the financials table for reported earnings per share.

Is SAPL Shariah compliant?

No Shariah screening status is shown for SAPL as of 27 Oct 2023.

Where is the head office of Sanofi-Aventis Pakistan?

The head office of Sanofi-Aventis Pakistan (SAPL) is at Plot No 23, Sector 22 Korangi Industrial Area Karachi, Pakistan (PSX company page, 7 Nov 2026).

Who is the auditor of Sanofi-Aventis Pakistan?

The auditor of Sanofi-Aventis Pakistan (SAPL) is A. F. Ferguson & Co. Chartered Accountants (PSX company page, 7 Nov 2026).

Who is the share registrar of Sanofi-Aventis Pakistan?

The share registrar of Sanofi-Aventis Pakistan (SAPL) is FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi (PSX company page, 7 Nov 2026).

When does the financial year of Sanofi-Aventis Pakistan end?

The financial year of Sanofi-Aventis Pakistan (SAPL) ends in December (PSX company page, 7 Nov 2026).

How many shares of Sanofi-Aventis Pakistan are outstanding?

Sanofi-Aventis Pakistan (SAPL) has 9,644,800 shares outstanding (PSX company page, 7 Nov 2026).

What is the free float of Sanofi-Aventis Pakistan?

The free float of Sanofi-Aventis Pakistan (SAPL) is 10% of its shares (PSX company page, 7 Nov 2026).

What does Sanofi-Aventis Pakistan do?

The company profile on PSX (7 Nov 2026) reads: The Company was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 (now Companies Act, 2017). The Company is a subsidiary of Sanofi Foreign Participations B.V. registered in Netherlands.

Answers use the facts on this page. Prices are as of 27 Oct 2023.

12SourcesGuides, filings and sources

Guides for SAPL

Plain explanations of the figures on this page.

Filings and reports

Sanofi-Aventis Pakistan filings and reports

43 documents Sanofi-Aventis Pakistan has published — annual reports, quarterly accounts and briefing decks. PSX filings are marked PSX; the rest come from the company’s own investor relations page. Links open the original PDF at the source.

Filings in SuperX Apex

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .

Track SAPL in your portfolio, from 23 December

Trade logging, price alerts and smart-money flows for PSX investors. Join the waitlist and we email once, when it is ready.

SuperX is not a broker and not an adviser. It never places an order and never asks for a broker login.

Get early access, free